Yesheng Du, RT

Department of Radiation Oncology, Chongqing University Cancer Hospital
Chongqing, Chong Qing

Disclosures:

  • Employment: none
  • Compensation: none
  • Ownership: none
  • Leadership: none

Presentations

Sep 29

3459 - Phase II Trial of QL1706 in Combination with Liposomal Irinotecan for Recurrent or Metastatic Nasopharyngeal Carcinoma Progressing after Anti-PD-(L)1 Therapy
Poster Hall - Exhibit Hall A
03:45pm - 05:00pm ET